Back to results
US 2025/0019349 A1Published application
Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell disease
AssigneesVirginia Commonwealth University, IllExcor Therapeutics, LLC, King Abdulaziz University, Children's Hospital of Philadelphia (Chop)
InventorsMartin SAFO, Yan ZHANG, Andrew FLEISCHMAN, David LIGHT, Moustafa EL-ARABY, Abdelsattar OMAR, Osheiza ABDULMALIK
Life of this patent
Estimating the term…
Abstract
Compounds and methods for preventing and/or treating one or more symptoms of sickle cell diseases (SCD) by administering at least one of the compounds are provided. The compounds are chemically modified to increase bioavailability and activity, e.g., so that the compounds prevent adhesion and sickling of red blood cells (RBCs).
Claims5
A compound having a formula
- wherein
- W, X, Y and Z are the same or different and are independently C or N, with the proviso that at least one of W, X, Y and Z is N;
- P is a promoiety;
- and
- R1, R2, R3, and r4 are the same or different and independently F, Cl or H, and pharmaceutically acceptable salts thereof.
2 more elements
Dependencies are inferred from the claim text.